1. Home
  2. WWW vs NTLA Comparison

WWW vs NTLA Comparison

Compare WWW & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wolverine World Wide Inc.

WWW

Wolverine World Wide Inc.

N/A

Current Price

$24.75

Market Cap

1.6B

ML Signal

N/A

Logo Intellia Therapeutics Inc.

NTLA

Intellia Therapeutics Inc.

N/A

Current Price

$10.04

Market Cap

1.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WWW
NTLA
Founded
1883
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Shoe Manufacturing
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
2003
2016

Fundamental Metrics

Financial Performance
Metric
WWW
NTLA
Price
$24.75
$10.04
Analyst Decision
Buy
Buy
Analyst Count
11
20
Target Price
★ $25.80
$22.78
AVG Volume (30 Days)
1.1M
★ 4.3M
Earning Date
11-12-2026
11-05-2026
Dividend Yield
★ 1.60%
N/A
EPS Growth
★ 96.55
27.43
EPS
★ 1.40
N/A
Revenue
★ $1,874,300,000.00
$67,671,000.00
Revenue This Year
$7.18
N/A
Revenue Next Year
$5.95
$174.74
P/E Ratio
$17.85
★ N/A
Revenue Growth
6.80
★ 16.92
52 Week Low
$14.00
$8.09
52 Week High
$25.99
$18.48

Technical Indicators

Market Signals
Indicator
WWW
NTLA
Relative Strength Index (RSI) 64.46 39.81
Support Level $18.65 N/A
Resistance Level N/A $13.59
Average True Range (ATR) 1.30 0.78
MACD 0.28 -0.18
Stochastic Oscillator 78.68 25.00

Price Performance

Historical Comparison
WWW
NTLA

About WWW Wolverine World Wide Inc.

Wolverine World Wide Inc is engaged in designing, manufacturing, sourcing, marketing, licensing, and distributing branded footwear, apparel, and accessories. The company's segment includes Active Group; and Work Group. It generates maximum revenue from the Active Group segment. Active Group segment consists of Merrell footwear and apparel, Saucony footwear and apparel, Sweaty Betty activewear, and Chaco footwear. Geographically, the company operates in United States; Europe, Middle East and Africa; Asia Pacific; Canada; and Latin America.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: